What's new

Human medicines European public assessment report (EPAR): Sarclisa, isatuximab, Date of authorisation: 30/05/2020, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Sarclisa, isatuximab, Date of authorisation: 30/05/2020, Revision: 12, Status: Authorised

Mar 12, 2025 - 15:51
 0
Human medicines European public assessment report (EPAR): Sarclisa, isatuximab, Date of authorisation: 30/05/2020, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Sarclisa, isatuximab, Date of authorisation: 30/05/2020, Revision: 12, Status: Authorised
Read More

Tags:

Previous Article

STAT+: Should health care providers tell patients they are using AI? 

Next Article

Gas appliances suffer setback in Washington state

Related Posts

Orphan designation: Trehalose Treatment of neuronal ceroid lipofuscinosis, 19/10/2020 Withdrawn

Orphan designation: Trehalose Treatment of neuronal cer...

Mar 12, 2025  0

Minutes of the CAT meeting 22-24 January 2025

Feb 27, 2025  0

Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) meetings

Executive Steering Group on Shortages and Safety of Med...

Feb 9, 2025  0